Downregulated miR-328 suppressed cell invasion and growth in hepatocellular carcinoma via targeting PTEN

被引:3
|
作者
Liang, F. [1 ,2 ]
Cui, Z. -J. [2 ]
Liu, J. -D. [2 ]
Liu, K. -P. [2 ]
Li, L. [2 ]
Chen, Y. -L. [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China
[2] Peoples Hosp Rizhao, Dept Hepatobiliary Surg, Rizhao, Peoples R China
关键词
miR-328; Hepatocellular carcinoma (HCC); Proliferation; Invasion; BREAST-CANCER; EXPRESSION; BIOGENESIS; RESISTANCE; MICRORNAS; GENE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To investigate the regulatory effect of miR-328 on biological behaviors of hepatocellular carcinoma (HCC) cells, such as invasion and proliferation. PATIENTS AND METHODS: The expressions of miR-328 were detected in 48 pairs of HCC tissue samples and matched adjacent tissues, as well as in 3 kinds of HCC cell lines via quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Further, we analyzed the effects of miR-328 inhibition on cell invasion, proliferation, cell apoptosis, and cell cycle. Dual-luciferase activity assay was performed to examine the potential target gene PTEN which was predicted by an online database. Protein levels were detected using Western blot assay. RESULTS: The expression of miR-328 was significantly increased in HCC tissue samples. Decreased miR-328 in HCC cells significantly attenuated cell invasion and proliferation capacities, promoted cell apoptosis and induced cell cycle arrest at GO/G1 phase. Moreover, PTEN was verified as a target gene of miR-328 by dual-luciferase activity assay, qRT-PCR and Western blot. Furthermore, the silence of PTEN neutralized the suppressive effect of decreased miR-328 on cell growth and metastasis. CONCLUSIONS: MiR-328 is involved in the development of HCC via regulating PTEN, which might provide a new target for HCC diagnosis and therapy.
引用
收藏
页码:6324 / 6332
页数:9
相关论文
共 50 条
  • [31] miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2
    Huang, Weizhen
    Li, Jun
    Guo, Xiaohong
    Zhao, Yingchu
    Yuan, Xia
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 81 : 431 - 438
  • [32] miR-21 promotes cell migration and invasion of hepatocellular carcinoma by targeting KLF5
    Wang, Jian
    Chu, Yanfeng
    Xu, Mei
    Zhang, Xiumei
    Zhou, Yumei
    ONCOLOGY LETTERS, 2019, 17 (02) : 2221 - 2227
  • [33] MiR-888 promotes cell migration and invasion of hepatocellular carcinoma by targeting SMAD4
    Li, Y-B
    Sun, F-N
    Ma, X-Y
    Ou, H.
    Yu, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (05) : 2020 - 2027
  • [34] miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN
    Feng, Hongxiang
    Zhang, Zhenrong
    Qing, Xin
    French, Samuel W.
    Liu, Deruo
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 108 : 105 - 113
  • [35] MiR-124a suppressed cell migration and invasion via AGR2 in oral squamous cell carcinoma
    Wang, Mengli
    Lai, Heqing
    PANMINERVA MEDICA, 2020,
  • [36] Depletion of DNMT3A Suppressed Cell Proliferation and Restored PTEN in Hepatocellular Carcinoma Cell
    Zhao, Zhujiang
    Wu, Qingxiang
    Cheng, Jian
    Qiu, Xuemei
    Zhang, Jianqiong
    Fan, Hong
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [37] MiR-186 Suppressed Growth, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting Dicer1
    Wang, Juan
    Zhang, Yi
    Ge, Fanghong
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [38] miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway
    Lv, Bo
    Liu, Xianzhuo
    Zhu, Xinfeng
    Huang, Min
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [39] miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway
    Bo Lv
    Xianzhuo Liu
    Xinfeng Zhu
    Min Huang
    World Journal of Surgical Oncology, 20
  • [40] miR-93 enhances hepatocellular carcinoma invasion and metastasis by EMT via targeting PDCD4
    Chunmei Ji
    Hang Liu
    Qiang Yin
    Hui Li
    Han Gao
    Biotechnology Letters, 2017, 39 : 1621 - 1629